Diebold Nixdorf Statistics
Total Valuation
DBD has a market cap or net worth of $1.65 billion. The enterprise value is $2.46 billion.
Market Cap | 1.65B |
Enterprise Value | 2.46B |
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DBD has 37.57 million shares outstanding. The number of shares has decreased by -49.87% in one year.
Current Share Class | 37.57M |
Shares Outstanding | 37.57M |
Shares Change (YoY) | -49.87% |
Shares Change (QoQ) | -0.27% |
Owned by Insiders (%) | 0.56% |
Owned by Institutions (%) | 75.23% |
Float | 27.06M |
Valuation Ratios
The trailing PE ratio is 14,249.19 and the forward PE ratio is 9.98.
PE Ratio | 14,249.19 |
Forward PE | 9.98 |
PS Ratio | 0.42 |
Forward PS | 0.41 |
PB Ratio | 1.51 |
P/TBV Ratio | n/a |
P/FCF Ratio | 16.56 |
P/OCF Ratio | 13.91 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.06, with an EV/FCF ratio of 25.29.
EV / Earnings | 12,277.77 |
EV / Sales | 0.65 |
EV / EBITDA | 6.06 |
EV / EBIT | 9.04 |
EV / FCF | 25.29 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 1.02.
Current Ratio | 1.45 |
Quick Ratio | 0.71 |
Debt / Equity | 1.02 |
Debt / EBITDA | 2.72 |
Debt / FCF | 11.33 |
Interest Coverage | 1.61 |
Financial Efficiency
Return on equity (ROE) is 0.19% and return on invested capital (ROIC) is 7.48%.
Return on Equity (ROE) | 0.19% |
Return on Assets (ROA) | 4.28% |
Return on Capital (ROIC) | 7.48% |
Revenue Per Employee | $180,905 |
Profits Per Employee | $10 |
Employee Count | 21,000 |
Asset Turnover | 0.96 |
Inventory Turnover | 4.38 |
Taxes
In the past 12 months, DBD has paid $57.30 million in taxes.
Income Tax | 57.30M |
Effective Tax Rate | 96.63% |
Stock Price Statistics
The stock price has increased by +77.96% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +77.96% |
50-Day Moving Average | 44.16 |
200-Day Moving Average | 39.54 |
Relative Strength Index (RSI) | 47.63 |
Average Volume (20 Days) | 245,994 |
Short Selling Information
The latest short interest is 343,038, so 0.91% of the outstanding shares have been sold short.
Short Interest | 343,038 |
Short Previous Month | 343,511 |
Short % of Shares Out | 0.91% |
Short % of Float | 1.27% |
Short Ratio (days to cover) | 2.15 |
Income Statement
In the last 12 months, DBD had revenue of $3.80 billion and earned $200,000 in profits. Earnings per share was $0.00.
Revenue | 3.80B |
Gross Profit | 936.20M |
Operating Income | 271.50M |
Pretax Income | -390.00M |
Net Income | 200,000 |
EBITDA | 405.10M |
EBIT | 271.50M |
Earnings Per Share (EPS) | $0.00 |
Balance Sheet
The company has $262.40 million in cash and $1.10 billion in debt, giving a net cash position of -$838.00 million or -$22.31 per share.
Cash & Cash Equivalents | 262.40M |
Total Debt | 1.10B |
Net Cash | -838.00M |
Net Cash Per Share | -$22.31 |
Equity (Book Value) | 1.08B |
Book Value Per Share | 28.38 |
Working Capital | 587.00M |
Cash Flow
In the last 12 months, operating cash flow was $115.60 million and capital expenditures -$18.50 million, giving a free cash flow of $97.10 million.
Operating Cash Flow | 115.60M |
Capital Expenditures | -18.50M |
Free Cash Flow | 97.10M |
FCF Per Share | $2.58 |
Margins
Gross margin is 24.64%, with operating and profit margins of 7.15% and 0.01%.
Gross Margin | 24.64% |
Operating Margin | 7.15% |
Pretax Margin | 1.56% |
Profit Margin | 0.01% |
EBITDA Margin | 10.66% |
EBIT Margin | 7.15% |
FCF Margin | -8.89% |
Dividends & Yields
DBD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 49.87% |
Shareholder Yield | 49.87% |
Earnings Yield | 0.01% |
FCF Yield | 6.04% |
Analyst Forecast
The average price target for DBD is $57.50, which is 30.53% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $57.50 |
Price Target Difference | 30.53% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
DBD has an Altman Z-Score of 1.65 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.65 |
Piotroski F-Score | 6 |